Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

NCT04371185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: BAT2206
DRUG: Stelara(US-licensed)
DRUG: Stelara(EU-licensed)

Sponsor

Bio-Thera Solutions